L1: Unmet medical needs Flashcards

1
Q

how many drugs are made in north america?
prescriptions?

A

> 1000 drugs
3.4 billion prescriptions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are first-in-class drugs

A

drug that targets a protien that hasnt been targeted before by another drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is a me-too drug

A

drug that targets a protein that has been targeted before by another drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the phases in the drug development pipeline?

A

related to the flow in one direction of creating a drug
- prelinical/discovery
- IND
- phase I, II, III
- NDA
- Phase IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how many years does each phase take and what is the test population, purpose and success rate for each? plus the intermediate trials

study the chart!!!!!!!!!

A

discovery/preclinical testing:
years: 6.5
test pop: lab and animal
purpose: assess safety, bio, and formulations
success rate: 5000 compounds evaluated

File IND to FDA:
purpose: propose the drug to he FDA and explain the new drug’s safety and potential efficacy based on preclinical studies. if approved, clinical trials begin

phase 1:
years: 1.5
test pop: 20-100 healthy people
purpose: safety and dosage
success rate: 5 drugs enter trials

phase 2:
years: 2
test pop: 100-500 patients
purpose: evaluate effectiveness and look for side effects
success rate: 5 drugs enter trials

phase 3:
years: 3.5
test pop: 1000-5000 patients
purpose: confirm effectiveness, long term effects
success rate: 5 drugs enter trials

File NDA at FDA:
purpose: the FDA, review the NDA to determine whether the drug is safe and effective for its intended use. if approved, drug can hit the market.

FDA:
years: 1.5
test pop: -
purpose: review and approval process
success rate: 1 drug approved

Phase 4:
purpose: additional post marketing testing required by FDA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how does the drug development pipeline reduce risk?

A
  • de-risking drug candidate from one step to the next
  • ethically it is dangerous to expose a drug that is not evaluated

phase 1: small experiments on drug
phase 2: if drug safe, continue clinical trials
phase 3: if drug perfoms well under clinical trials (efficacy), confirm with larger numbers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the list of essential medicines? what does it take into account (8 things) ?

A

book that posts the list of essential medicines. published every two years by the WHO.

Takes into account:
* prevalence
* how serious is the disease: impact on disability-adjusted life years, DALYs
* public health, community health
* evidence of efficacy (that the drug works)
* evidence that the drug is safe
* list includes cost-effective drugs
* value for $ - WHO has a global mandate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

who decides what drugs are important for development (6 things)

A

all things considered, like:
- an evaluation of the therapeutic need
- global burden of the disease
- prediction of the trend of the disease’s burden
- patient voices

medical need
- Is the condition life-threatening or self-limiting?
- how long does the medical condition last

Availability of Current Therapy
– the current treatment satisfactory
would a new drug be better?
- increase efficacy?
- more safe?
– Fewer side effects?
– More convenient to take (once a day)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the steps in the drug discovery/preclinical phase of the pipeline?

what is a drug target and how does it relate to this phase?

A

Drug target: A molecule (usually a protein) involved in the disease, that the drug binds to, often inactivation the molecule

Steps of the drug discovery phase:
1. choose a disease mechanism and model
2. identify and validate the drug target of the disease. can a drug even bind to this protein (it has to be able to to be a drug target)
3. test thousands of chemicals against the drug target. if its a smaller chemical it can move in the body well, be safer, and have a better effect on the target
4. test the drug in at least two animal species as a safety requirement (by the FDA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

explain the purpose, design, and subjects in the phase 1 clinical trials

A

Purpose
– Determine a safe drug dose
– determine pharmacokinetics – what happens and how does the the drug move in the body.

Design
– cautious trials of dose escalation. do trials with a low dose then increase it to see which is the most effective.

Subjects
– healthy normal volunteers usually
– Sometimes patients with the disease (cancer) – not usual
– Must obtain informed consent from subjects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what do phase 1 ads include

A

usually specify what the requirement of the volunteer is:
- aka the age group and the fact that they are healthy
- brief intro to the clinical trial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

explain the objective, subjects, and design in a phase 2 clinical trial

A

Objective
- To obtain preliminary information on the efficacy of the drug
- Efficacy: does the drug work to treat the medical condition? does it achieve its purpose?

Subjects
- Patients with the disease

Design
- Compare treated individuals to control individuals (placebo)
- compare results

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what does a phase 2 clinical trial ad look like

A
  • asks if the person has the disease they are looking to treat
  • specifically states that they have to be experiencing symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

why do phase 2 clinical trials use placebos?
what is the placebo effect

A

Placebos
– Placebos look like real pills but contain no active drug ingredient
– serves as a baseline measurement. the scientists can measure the effect of the treatment vs no treatment, while accounting for the placebo effect

Placebo effect
- the placebo effect is the psychological effect of one taking a drug and thinking its working, even though it has no medicinal properties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how can the confidence in clinical trials (phase 2) be improved?

A

we can increase the confidence of our results by using blinding in the experimental method to reduce bias
* Single-blind: subjects unaware if they get the treatment or placebo
* Double-blind: neither subjects nor researchers know who took what drug
- the computer knows who took what

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

explain the objective, design and subjects of phase 3 trials

A

Objective
– To compare efficacy of the new treatment with the standard regimen

Design
– Usually randomized control

Subjects
– Patients with the disease
– more patients (inc by like 1000) than phase 2

17
Q

what do phase 3 ads look like

A

attracting people that suffer with the disease
very similar to phase 2 ads
attracting a larger popularion of people.

18
Q

what is informed consent

A

the process of understanding what you are agreeing (consent) to.

19
Q

what do people choose to participants in clinical trials (5)

A

advance medicine
help the lives of others
help improve their own condition
get money
free medical care

(in order of decreasing reason)

20
Q

explain phase 4 of the pipeline.

what is its purpose, what do companies ask for for producing the drug. how much does it cost to get a single drug to the market.

A
  • the drug is on the market after approval of the NDA by the FDA
  • companies ask for a patent protection. This protection helps companies recoup the significant investment in research and development and encourages ongoing innovation.
  • generic drugs are off patent
  • > 2 B dollars (includes cost of failures) to get a drug to the market
  • the cost of failure usually outweighs the cost of the molecule
  • 15 years duration
21
Q

what are challenges in drug development

A
  • conflict between money and lives
  • participant attrition: participants often leave and don’t participate in all trials because of other commitments. hard for drug development